Search

everythinglearnresearchcommunity

for

Search:↓

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Low-dose Minoxidil combined with Spironolactone helps reduce hair loss and improve hair density in women, with some mild side effects.

Sublingual minoxidil improved hair growth in a 10-year-old boy without side effects.

Minoxidil 0.25 mg with spironolactone 25 mg reduces hair loss and improves hair density in women.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

The new visual scale is a quick and effective way to measure hair loss in women.

Rosmarinus officinalis tincture significantly improves hair volume and density.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Oral minoxidil reduced hair shedding in women with chronic telogen effluvium.

Oral minoxidil effectively reduces hair shedding in women with chronic telogen effluvium.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

New shampoo with tyramine hydrochloride reduces hair loss by making a small muscle in the hair follicle contract.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

Some alopecia treatments might help treat COVID-19, but more research is needed.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

New treatment reduces hair shedding and increases hair density in women with early hair loss.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.